Mckesson (MCK) EBIT Growth (3y) (2012 - 2026)
Mckesson (MCK) EBIT Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 29.94% |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 26.79% |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | -3.82% |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 1.32% |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 85.70% |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 20.42% |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | -1.40% |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | 66.97% |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 6.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.94% |
| Dec 31, 2025 | 9.27% |
| Sep 30, 2025 | 7.77% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 35.96% |
| Dec 31, 2024 | 60.15% |
| Sep 30, 2024 | 2.36% |
| Jun 30, 2024 | 21.91% |
| Mar 31, 2024 | 6.38% |
| Dec 31, 2023 | 27.80% |
| Sep 30, 2023 | 14.47% |
| Jun 30, 2023 | 17.50% |
| Mar 31, 2023 | 4.09% |
| Dec 31, 2022 | 51.06% |
| Sep 30, 2022 | 21.54% |
| Jun 30, 2022 | 17.79% |
| Mar 31, 2022 | 46.01% |
| Dec 31, 2021 | -24.15% |
| Sep 30, 2021 | -7.86% |
| Jun 30, 2021 | 89.86% |